TAG:
Medicaid
Pathologists Take Images to the Cloud
CEO SUMMARY: Scaled-up operations, streamlined logistics, and potential cybersecurity benefits all present a valid argument for pathology practices to move their data to the cloud. Digital pathology in particular stands to gain from a cloud-based setup that allows remote v…
Profitable Collaboration with Pharma Companies
CEO SUMMARY: Drug discovery efforts by pharmaceutical companies often need a boost from anatomic pathology practices and clinical laboratories. Forward-thinking lab leaders and pathologists can take advantage of their data and expertise to partner with pharma, setting the …
Former Payer CEO Posts Sharp Comments on LinkedIn
FORMER CEO OF PUBLICLY-TRADED INSURANCE COMPANY MOLINA HEALTHCARE, J. Mario Molina, MD, took to LinkedIn in July offering a sobering perspective on the current state of the private payer industry. Drawing on his 14 years at the helm, Molina remarked, “What’s happening right now does…
For AI Regulation, Look to Data Laws, FDA Action
CEO SUMMARY: AI is creating legal uncertainty for clinical labs, especially around data privacy and FDA oversight of AI tools in diagnostics. Few court cases exist yet that interpret AI use within clinical settings, but labs must watch how HIPAA and state laws wield influence. Vendor soft…
Regional Health Systems Are New Dominant Players in M&A
READERS OF THE DARK REPORT UNDERSTAND HOW INTERTWINED THEIR CLINICAL LAB BUSINESS is with healthcare system mergers and acquisitions (M&A). Thus, financial service firm Morgan Stanley’s recent report on M&A activity in the healthcare industry will be of inte…
How Medicaid Cuts May Affect Clinical Labs
CEO Summary: As lawmakers debate the merits of President Donald Trump’s budget bill, it appears that Medicaid changes are on the horizon. For medical laboratories, three immediate areas to monitor include potentially decreased Medicaid recipients, federal cuts to Medicai…
June 2, 2025, Intelligence: Late-Breaking Lab News
Our sibling publication, G2 Intelligence, reported in May about a new Department of Justice (DOJ) memorandum that indicated prosecutors will seek to exercise fairness when deciding how to pursue fraud cases against clinical laboratories and other organizations. The DOJ emphasiz…
Economic, Tech Changes Drive Lab Concerns
CEO SUMMARY: Uncertainty around tariffs, future regulations, and artificial intelligence (AI) defined the mood at the 2025 Executive War College, where nearly 1,000 lab leaders gathered. Speakers warned of how stagnant healthcare spending could trickle down to labs. Meanwh…
OPKO Settles Allegations of Fraudulent Billing
DEMONSTRATING THAT EVEN ROUTINE TESTS CAN CAUSE LEGAL HEADACHES for clinical laboratories, the U.S….
Managing Denials and Appeals of Clinical Lab, Path Claims
CEO SUMMARY: Based on a study of denials and appeals involving about 20 million lab test claims, the team at XiFin Inc. presents here their findings. They also provide recommendations on steps labs can take to reduce denials and win a greater proportion of appeals. IN RECENT…
CURRENT ISSUE
Volume XXXII, No. 17 – December 8, 2025
Laboratory professionals are urged to make their voices heard in Congress as the end of a brief reprieve to PAMA cuts comes on January 30, 2026. Congress is said to be inclined to address reformation of PAMA now. Also, pathologists are slowly switching to cloud storage for their digital slides.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.